Demir Elementinin Fiziksel, Kimyasal ve Biyolojik Özellikleri: İnsan Sağlığı İçin Önemi

Brannon, P. M., & Taylor, C. L. (2017). Iron supplementation during pregnancy. The Am J Clin Nutr, 106 (Suppl 6), 1567S–1573S.

Andrews, N. C. (1999). Disorders of iron metabolism. New Engl J Med, 341(26), 1986–1995.

National Institutes of Health. (2022). Iron: Fact sheet for health professionals. Office of Dietary Supplements.

Habashi, F. (2013). Iron, Physical and Chemical Properties. In: Kretsinger, R.H., Uversky, V.N., Permyakov, E.A. (eds) Encyclopedia of Metalloproteins. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1533-6_417.

O'Neil, M.J. (2001),(ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., p. 915.

World Nuclear Association. Radioisotopes in Industry: Industrial Uses of Radioisotopes, World Nuclear Association (2014), Feb. 24; http://www.world-nuclear.org/info/inf56.html.

Australian Government, Australian Nuclear Science and Technology Organisation (Ansto). [Radioisotopes]:/their Role in Society Today/, Australian Government, Australian Nuclear Science and Technology Organisation (Ansto) (2014), Feb. 24; http://www.ansto.gov.au/__data/assets/pdf_file/0018/3564/Radioisotopes.pdf.

AUS-e-TUTE for Astute Science Students. Chemistry Tutorial: Summary of Radioactive Particles, Isotopes, Properties and Uses, AUS-e-TUTE for Astute Science Students (2014), Feb. 24; http://www.ausetute.com.au/nuclesum.html.

Z. Chen, I. J. Griffin, L. M. Plumlee, S. A. Abrams. J.,(2005). Nutr.135, 1790.

S. A. Abrams. (1999). Am. J. Clin. Nutr.70, 955.

N. Dauphas, O. Rouxel. (2006). Mass Spectrom. Rev.25, 515.

World Nuclear Organisation. Radioisotopes in Medicine, World Nuclear Organisation (2014), 23 February ; http://www.world-nuclear.org/info/inf55.html .

M. Bruehlmeier, KL Leenders, P. Vontobel, C. Calonder, A. Antonini, A. Weindl. (2000). J Nucl Med.41, 781

A. Agool, AW Glaudemans, HH Boersma, RA Dierckx, E. Vellenga, RH Slart. Avro. J. (2011).Nucl. Med. Mol. Imaging 38, 166.

F. Haddad, L. Ferrer, A. Guertin, T. Carlier, N. Michel, J. Barbet, JF Chatal. Avro. J. (2008). Nucl Med Mol. Imaging 35, 1377.

Nemeth, E., & Ganz, T. (2006). Regulation of iron metabolism by hepcidin. Annual Review of Nutrition, 26, 323–342.

Ward, R. J., Crichton, R. R., & Taylor, D. L. (2017). Iron and the brain: neurodegeneration and neuroprotection. Int J Mol Sci, 18(11), 2438.

World Health Organization. (2001). Iron deficiency anaemia: Assessment, prevention and control. Geneva: WHO.

Kaplan J, Ward, D. M., De Domenico, I., (2011). “The molecular basis of iron overload disorders and iron linked anemias”, Int J Hematol. 93, 1, 14-20,.

Ganz, T., & Nemeth, E. (2008). Hepcidin and systemic iron homeostasis. New Engl J Med, 357(3), 2383–2397.

Hentze, Matthias W et al. Cell, Volume 117, Issue 3, 285 – 297. https://www.cell. com/fulltext/S0092-8674%2804%2900343-5.

https://studycorgi.com/literature-review-of-hepcidin-importance-production-regulation/ (erişim tarihi:14.04.2025).